Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis-Reference-Cited by-同舟云学术

Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis

Published:2019-05-01 Issue:9 Volume:58 Page:1263-1266
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kono Masashi¹,Sakurai Toshiharu¹,Okamoto Kazuki¹,Masaki Shou¹,Nagai Tomoyuki¹,Komeda Yoriaki¹,Kamata Ken¹,Minaga Kosuke¹,Yamao Kentarou¹,Takenaka Mamoru¹,Watanabe Tomohiro¹,Nishida Naoshi¹,Kudo Masatoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/9/58_1981-18/_pdf

Reference23 articles.

1. 1. Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390: 2461-2471, 2017.

2. 2. Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist 12: 864-872, 2007.

3. 3. Kumar V, Chaudhary N, Garg M, et al. Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy. Front Pharmacol 8: 49, 2017.

4. 4. Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology 44: 1063-1074, 2006.

5. 5. Kulaksiz H, Heuberger D, Engler S. et al. Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40: 214-218, 2008.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of immune-related cystitis by Chai-Ling-Tang (Sairei-To) in a gastric carcinoma patient: Case report and literature review;EXPLORE;2023-05

2. Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review;Advances in Anatomic Pathology;2023-04-10

3. Progression from early to advanced stage of immune‐related cholangitis;Hepatology Research;2022-08-15

4. Gastrointestinal and Hepatobiliary Immune-related Adverse Events: A Histopathologic Review;Advances in Anatomic Pathology;2022-04-26

5. Clinical Characteristics of ICI-Related Pancreatitis and Cholangitis Including Radiographic and Endoscopic Findings;Healthcare;2022-04-20